Clinical study for Preoperative clopidogrel individualized withdrawal time based on TEG

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028558

Enrollment

Unknown

Registered

2019-12-27

Start date

2020-01-10

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse cardiac and cerebrovascular events

Interventions

Case series:Surgery patients receiving clopidogrel

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Noncardiac general anesthesia patients receiving clopidogrel antiplatelet therapy

Exclusion criteria

Exclusion criteria: (1) intracranial, intraspinal and intraocular surgery; (2) patients taking other anticoagulant drugs; (3) patients with severe hematological diseases.

Design outcomes

Primary

Measure	Time frame
Intraoperative blood loss and drainage within 24 hours;	—

Countries

China

Contacts

Public ContactDai Zeping

The First Affiliated Hospital of Wannan Medical College, Jijishan Hospital

zpdai@wnmc.edu.cn+86 13955365823

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026